Rise Therapeutics

Rise Therapeutics specializes in developing targeted immunological biologics using a unique and proprietary oral delivery platform. The company focuses on creating first-in-class immune modulatory drugs aimed at treating inflammation, autoimmunity, infection, and cancer. Rise Therapeutics operates in the biotechnology and pharmaceutical markets, serving academic institutions, biotechnology firms, and pharmaceutical companies. The business model revolves around research and development, clinical GMP manufacturing, and strategic partnerships. Revenue is generated through the development and commercialization of novel drugs, as well as offering manufacturing services for microbiome-based medicines. The company leverages its scientific and regulatory expertise to support both emerging and established companies in product development and manufacturing.

Keywords: immunological biologics, oral delivery, immune modulatory drugs, inflammation, autoimmunity, infection, cancer, microbiome science, GMP manufacturing, biotechnology.